Education Students Posters Resources Engage Destination Supporters #BeThe1To

Log in for full access to this activity, if you are registered.

Registration Options

Activity Date: 04/09/2019

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

The DSM-5 was published in 2013 with a significant change in the categorization of PTSD, from Anxiety disorder to Trauma/Stressor related disorder, based on a better understanding of the pathophysiology of the disorder. PTSD can be a disabling condition and can occur in not only war survivors, but also survivors of child abuse, violence, motor vehicle accidents, and world and national disasters to name a few. Advances in the understanding of the pathophysiology of PTSD have led to the recognition of multiple changes in neurophysiology related to PTSD which are new targets for novel therapies. In this session, participants will enhance their understanding of the pathophysiology and most up to date results of trials to enhance treatment recommendations when a standard pharmacotherapy is ineffective.

Course Requirements

To receive ACPE credit for the live session at the Annual Meeting, you must:

  • Attend and participate in the entire session and reflect upon its teachings.
  • Complete the evaluation and the self-assessment questions at the end of the activity. (login first)
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course will be provided at the CPNP 2019 Annual Meeting, April 7-10, 2019. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at http://cpnp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Learning Objectives

  1. Describe the current understanding of the pathophysiology of PTSD.
  2. Provide an overview of evidence-based pharmacotherapies for PTSD.
  3. Explain the quality and consistency of current trials utilizing novel pharmacotherapeutic approaches to treating PTSD.

Continuing Education Credit and Disclosures

Activity Date: 04/09/2019
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-19-030-L01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.0 contact hour of knowledge-based continuing education credit from CPNP approved programming.